Navigation Links
Two In One Drug For Smokers And Drinkers

It could be described as the stone that kills two vices. United States FDA-approved smoking cessation drug varenicline , is posing to be handed out to alcoholics as well .

The Pfizer manufactured drug, sold under the name Chantix, which has been used quite successfully by smokers , was tested to reveal the same effects in alcoholics too, of the furry kind, lab rats.

Says Selena Bartlett, a University of California, San Francisco neuroscientist who led the study: "The biggest thrill is that this drug, which has already proved safe for people trying to stop smoking, is now a potential drug to fight alcohol dependence."

In the study, the researchers trained rats to drink alcohol and measured the effect of varenicline once the animals became the lab equivalent of heavy drinkers. They found the drug curbed their drinking. Even when stopped, the rats resumed drinking but did not binge.

The study is outlined in the journal Proceedings of the National Academy of Sciences.

The drug varenicline is said to work by latching onto the same receptors in the brain that nicotine binds to, when inhaled in cigarette smoke, an action that leads to the release of dopamine in the brain's pleasure centers. Taking the drug blocks any inhaled nicotine from enhancing that effect.

Varenicline has been available as a smoking cessation aid for nearly a year in the U.S. and the European Union, and as well as being safe it does not suppress the appetite and is not metabolized in the liver. According to Bartlett this is a major advantage because long-term drinkers often have liver damage. In addition, the drug has the potential to be considered as a treatment for addictions such as gambling and painkillers.

The University of California researchers, together with the U.S. National Institute on Alcohol Abuse and Alcoholism, are planning the first studies in humans of the drug's effectiveness in curbing alcohol cr avings and dependence, according to Bartlett.

At the same time, several experts not involved in the study warn that there is no such thing as a magic cure-all for addiction and that varenicline and such drugs may find more immediate use in treating diseases like Alzheimer's and Parkinson's.


'"/>




Related medicine news :

1. Smokers children likely to develop caries
2. Smokers more prone to depression
3. Female Smokers More Prone To Lung Cancer
4. Young Smokers at Increased Risk Of Developing a Heart Attack
5. Women Smokers More Prone To Lung Cancer
6. Creating A Greater Awareness Among Smokers
7. Smokers may differ in their cravings for smoking
8. Trained Counselors Counseling Pregnant Smokers To Quit May Not Work
9. Smokers Avoid Dental Care More Than Others
10. Smokers Face The Risk Of Becoming Blind In Later Life
11. New Vaccination For Smokers To Quit Smoking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2017)... (PRWEB) , ... May 21, 2017 , ... ... if it's been longer than six months since you've seen a dentist, it's ... twice per year and getting x-rays once per year. , Dental checkups are ...
(Date:5/19/2017)... ... May 19, 2017 , ... When Kyle Busch graduates from ... will already appear on two major research studies that could impact the health of ... Matt Daggett, KCU alumnus and an orthopedic surgeon, alongside an international team trying to ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Arnold ... Young Investigators: , Victor Acosta, Ph.D. - University of New Mexico, Jeremy Baskin, ... - University of Washington, Erik Grumstrup, Ph.D. - Montana Stata University, A. Fatih ...
(Date:5/19/2017)... ... 2017 , ... CloSYS products which are marketed as the gentle giants of ... and gum health, which is linked to one’s overall health. Since 1991 when the ... powerful ways in which CloSYS products immediately helped eliminate bad breath as well as ...
(Date:5/18/2017)... ... ... Originally launched to market as the EPIK Learning Tab, the highly successful ... of their product line, the company believed it was the right time to create ... be any tablet product sold by EPIK Learning. This year there will be ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
(Date:5/10/2017)... May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of the ... based on extensive data analysis from GHI,s hospitals database ... database for the region. The GHI database covers 86% of ... more than 130 data points for each institution in key ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
Breaking Medicine Technology: